15mgs" 649 upvotes, 48 comments 299 155 52 Female This is about two years difference
Some individuals find other medications like tirzepatide or dulaglutide more tolerable
sermorelin may increase IGF-1), compounded GI side effects (nausea, vomiting, constipation), potential fluid retention or joint symptoms from elevated growth hormone, and unknown long-term metabolic effects
4,7 In this regard, this addition ensures a more comprehensive discussion aligned with current expert consensus on risk mitigation strategies
This information can be valuable when discussing your treatment with your healthcare provider and may help identify patterns or triggers
Consistent with other GLP-1 agonists, orforglipron labeling is expected to include the standard boxed warning about thyroid C-cell tumors and a contraindication in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)